NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,037 | -2.0% | 24,867 | +0.6% | 0.00% | – |
| Q2 2023 | $183,647 | -68.3% | 24,717 | -70.4% | 0.00% | -100.0% |
| Q1 2023 | $579,438 | -32.6% | 83,613 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $859,542 | -44.3% | 83,613 | -1.4% | 0.00% | -50.0% |
| Q3 2022 | $1,544,000 | -64.6% | 84,813 | 0.0% | 0.00% | -63.6% |
| Q2 2022 | $4,362,000 | -36.1% | 84,813 | -8.5% | 0.01% | -15.4% |
| Q1 2022 | $6,829,000 | -48.9% | 92,716 | -0.7% | 0.01% | -45.8% |
| Q4 2021 | $13,364,000 | -30.7% | 93,411 | +0.4% | 0.02% | -36.8% |
| Q3 2021 | $19,289,000 | -5.0% | 93,042 | -2.7% | 0.04% | 0.0% |
| Q2 2021 | $20,303,000 | +378.1% | 95,628 | +308.2% | 0.04% | +375.0% |
| Q1 2021 | $4,247,000 | +49.3% | 23,426 | -8.2% | 0.01% | +33.3% |
| Q4 2020 | $2,845,000 | -7.7% | 25,516 | -10.3% | 0.01% | -14.3% |
| Q3 2020 | $3,083,000 | +45.7% | 28,456 | +12.1% | 0.01% | +40.0% |
| Q2 2020 | $2,116,000 | – | 25,386 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |